1175 YH006, a fully human Treg-depleting CTLA-4×OX40 bispecific antibody, demonstrates superior preclinical efficacy and favorable developability

相似書籍

• 1164 BSA01, a bispecific antibody-drug conjugate targeting EGFR and membrane-bound MUC-1-C, exhibits anti-tumor efficacy in vivo
  由: Hao Li, et al.
  出版: (2023-11-01)
• 1163 A novel bispecific antibody-drug conjugate targeting PTK7 and TROP2, BCG033, demonstrates preclinical efficacy against triple-negative breast cancer xenografts
  由: Yi Yang, et al.
  出版: (2023-11-01)
• 1153 BCG022: a HER3×MET bispecific antibody-drug conjugate (BsADC) targeting key mechanisms of bypass resistance in multiple tumor types
  由: Yi Yang, et al.
  出版: (2023-11-01)
• 1175 YH006, a fully human Treg-depleting CTLA-4×OX40 bispecific antibody, demonstrates superior preclinical efficacy and favorable developability
  由: Xiang Guo, et al.
  出版: (2023-11-01)
• Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody
  由: Jun Fang, et al.
  出版: (2023-07-01)